# US 6,727,072 B2 · EGF-r detection kit

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,072 B2
- Document ID: US6727072B2
- Status: Granted
- Kind: B2
- Application number: 09/846,551
- Filed: 2001-05-01
- Published: 2002-11-07
- Granted: 2004-04-27
- Earliest claimed: 2001-05-01
- Assignees: Dako Corporation
- Inventors: Elizabeth O. Spaulding; Marc E. Key
- Web page: https://patentgrep.com/patent/US6727072B2

## CPC

- G01N 33/567: utilising isolate of tissue or organ as binding agent
- G01N 33/66: involving blood sugars, e.g. galactose
- G01N 2474/20: Immunohistochemistry assay
- Y10S 435/975: Kit
- Y10S 436/808: Automated or kit
- Y10S 436/81: Tube, bottle, or dipstick
- Y10S 436/813: Cancer
- Y10S 436/822: Identified hapten
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

A kit containing the reagents necessary for the qualitative or quantitative demonstration of epidermal growth factor receptor (EGFR) in formalin-fixed, paraffin-embedded tissue sections. A immunohistochemical staining procedure is employed which utilizes a primary monoclonal mouse antibody that selectively binds to EGFR. The primary antibodies bound to tissue antigens are detected using a peroxidase labeled polymer that is conjugated with secondary anti-mouse immunoglobulin antibodies. The enzymatic conversion of the subsequently applied chromogen results in formation of a visible reaction product at the site of the EGFR antigen. Following development of the chromogen, specimens may then be counterstained and coverslipped. Results are interpreted using a light microscope or other optical imaging device. The detection system is adapted for both manual and automated staining.

## Claims

### Claim 1

A kit operable for detecting the presence of epidermal growth factor receptor in cells comprising a tissue, the kit comprising:
(a) a proteolytic enzyme comprising Proteinase K diluted in 0.05M Tris-HCl, 0.015M sodium azid, pH 7.5;
(b) a peroxidase;
(c) Monoclonal Anti-human EGFR antibody derived from a nonhuman source
(d) IgG1 Isotype Control comprising monoclonal IgG1 antibody derived from said nonhuman source;
(f) a visualization reagent comprising peroxidase labeled polymer conjugated to affinity-isolated anti-said nonhuman source immunoglobulins;
(g) a substrate for said peroxidase labeled polymer;
(h) a chromogen comprising 3,3′-diaminobenzidine;
(i) Tris Buffered Saline, pH 7.6; and
(j) a surfactant.

### Claim 2 (depends on 1)

A kit operable for detecting the presence of epidermal growth factor receptor in cells comprising a tissue in accordance with claim 1 further comprising Tris-based antibody diluent comprised of 0.05M Tris-HCl pH 7.6 containing stabilizing protein and 0.015M sodium azide.

### Claim 3 (depends on 1)

The kit operable for detecting the presence of epidermal growth factor receptor in cells comprising a tissue in accordance with claim 1 further comprising at least one control slide containing three pelleted, formalin-fixed, paraffin-embedded cell lines, which represent different amounts of the EGFR protein expression.

### Claim 4 (depends on 2)

The kit operable for detecting the presence of epidermal growth factor receptor in cells comprising a tissue in accordance with claim 2 further comprising at least one control slide containing three pelleted, formalin-fixed, paraffin-embedded cell lines, which represent different amounts of EGFR protein expression.

### Claim 5 (depends on 1)

The kit in accordance with claim 1 wherein said peroxidase block comprises 0.03% hydrogen peroxide containing sodium azide.

### Claim 6 (depends on 2)

The kit in accordance with claim 2 wherein said peroxidase block comprises 0.03% hydrogen peroxide containing sodium azide.

### Claim 7 (depends on 1)

The kit in accordance with claim 1 wherein said peroxidase block comprises 0.03% hydrogen peroxide containing sodium azide.

### Claim 8 (depends on 3)

The kit in accordance with claim 3 wherein said peroxidase block comprises 0.03% hydrogen peroxide containing sodium azide.

### Claim 9 (depends on 1)

The kit in accordance with claim 1 wherein said nonhuman source is a mouse.

### Claim 10 (depends on 1)

The kit of claim 1 wherein said IgG1 Isotype Control comprises monoclonal mouse IgG1 antibody in concentrated form at 100 μg/mL as tissue culture supernatant (containing fetal calf serum) dialyzed against 0.05M Tris-HCl, pH 7.2, and 0.015M sodium azide.

### Claim 11 (depends on 10)

The kit of claim 10 wherein said visualization reagent comprising peroxidase labeled polymer conjugated to affinity-isolated goat anti-mouse immunoglobulins in Tris-HCl buffer containing stabilizing protein and an antimicrobial agent.

### Claim 12 (depends on 1)

The kit of claim 1 wherein said substrate includes a substrate buffer Buffer comprising Imidazole-HCl buffer pH 7.5, containing hydrogen peroxide, stabilizers, enhancers and an antimicrobial agent.

### Claim 13 (depends on 1)

The kit of claim 1 wherein said surfactant is Tween 20.
